David A. Siegel Burning Rock Biotech LTD Transaction History

Two Sigma Advisers, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.75 - $10.44 $94,500 - $563,760	54,000 New	54,000 $157,000
Q1 2022 May 16, 2022	SELL	$6.7 - $10.23 $117,250 - $179,025	-17,500 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$9.43 - $17.14 $165,025 - $299,950	17,500 New	17,500 $167,000

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $687M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.